SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042555
Filing Date
2021-08-13
Accepted
2021-08-13 17:23:07
Documents
106
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_chinasxtpharmaceuti.htm 20-F 1813088
2 AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION, EFFECTIVE ON FEBRUA f20f2021ex1-3_chinasxtphar.htm EX-1.3 618378
3 2021 EQUITY INCENTIVE PLAN f20f2021ex4-6_chinasxtphar.htm EX-4.6 143481
4 CERTIFICATION f20f2021ex12-1_chinasxt.htm EX-12.1 10906
5 CERTIFICATION f20f2021ex12-2_chinasxt.htm EX-12.2 10817
6 CERTIFICATION f20f2021ex13-1_chinasxt.htm EX-13.1 4359
7 CONSENT OF INDEPENDENT AUDITORS f20f2021ex23-1_chinasxt.htm EX-23.1 3534
8 GRAPHIC img_001.jpg GRAPHIC 48066
9 GRAPHIC img_002.jpg GRAPHIC 38883
10 GRAPHIC image_001.jpg GRAPHIC 6019
17 GRAPHIC image_002.jpg GRAPHIC 6019
  Complete submission text file 0001213900-21-042555.txt   7065375

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE sxtc-20210331.xml EX-101.INS 765898
12 XBRL SCHEMA FILE sxtc-20210331.xsd EX-101.SCH 92105
13 XBRL CALCULATION FILE sxtc-20210331_cal.xml EX-101.CAL 42104
14 XBRL DEFINITION FILE sxtc-20210331_def.xml EX-101.DEF 300186
15 XBRL LABEL FILE sxtc-20210331_lab.xml EX-101.LAB 547796
16 XBRL PRESENTATION FILE sxtc-20210331_pre.xml EX-101.PRE 307826
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-38773 | Film No.: 211173431
SIC: 2834 Pharmaceutical Preparations